%A Segelmark,Mårten %A Björck,Lars %D 2019 %J Frontiers in Immunology %C %F %G English %K Vasculitis,ANCA,Streptococcus pygenes,Anti-GBM antibody disease,Autoantibodies %Q %R 10.3389/fimmu.2019.02165 %W %L %M %P %7 %8 2019-September-20 %9 Mini Review %# %! IdeS and EndoS as precision tools in small vessel vasculitis %* %< %T Streptococcal Enzymes as Precision Tools Against Pathogenic IgG Autoantibodies in Small Vessel Vasculitis %U https://www.frontiersin.org/articles/10.3389/fimmu.2019.02165 %V 10 %0 JOURNAL ARTICLE %@ 1664-3224 %X In primary systemic small vessel vasculitis autoantibodies are common and seem to play an important role in the pathogenesis. Autoantibodies in vasculitis are preferentially directed against components of the immune system or directly against components of the vessel wall. Plasmapheresis is often applied in emergency situationists when the function of vital organs is jeopardized, the level of clinical evidence to apply such therapy, however, varies between low and non-existing. Plasmapheresis is a blunt and unspecific instrument that requires several sessions to achieve a substantial reduction of autoantibody levels. IdeS and EndoS are two relatively recently discovered enzymes produced by S. pyogenes, that have a remarkable capacity to degrade and disarm IgG. They have shown positive results in several in vivo models of autoimmunity, and treatment with IdeS has successfully been used to inactivate HLA alloantibodies in patients undergoing renal transplantation. Both IdeS and EndoS have the potential to become precision tools to replace plasmapheresis in the treatment of vasculitic emergencies and a clinical trial of IdeS in anti-GBM vasculitis is now ongoing.